Summary
CVS Health Corporation (CVS) announced a significant addition to its Board of Directors with the election of Michael F. Mahoney, effective November 1, 2023. Mr. Mahoney brings a wealth of experience from the medical device and healthcare industries, having held prominent leadership roles including President and CEO of Boston Scientific and various executive positions at Johnson & Johnson and General Electric. His appointment is expected to strengthen the board's expertise in the healthcare sector. Investors should note that Mr. Mahoney has a proven track record in driving growth and innovation within complex healthcare organizations. His prior board experience, including his recent tenure at Baxter International, suggests a familiarity with corporate governance and strategic oversight. The company has affirmed Mr. Mahoney's independence, aligning with NYSE listing standards, and his compensation will be in line with existing non-employee director practices.
Key Highlights
- 1CVS Health has appointed Michael F. Mahoney to its Board of Directors, effective November 1, 2023.
- 2Mr. Mahoney is a seasoned executive with extensive experience in the healthcare and medical device sectors.
- 3He currently serves as President, CEO, and Chairman of Boston Scientific, a major global medical device company.
- 4Mr. Mahoney has prior leadership roles at Johnson & Johnson's DePuy franchise and General Electric Medical Systems.
- 5His appointment is considered an "independent" director under NYSE and CVS Health's governance guidelines.
- 6Mr. Mahoney previously served on the Board of Directors for Baxter International Inc. from 2015 to 2023.
- 7His compensation as a director will be consistent with other non-employee directors at CVS Health.